Table of Content

1 RNA-based Biopharmaceuticals Market Overview
1.1 Product Overview and Scope of RNA-based Biopharmaceuticals
1.2 RNA-based Biopharmaceuticals Segment by Type
1.2.1 Global RNA-based Biopharmaceuticals Market Value Comparison by Type (2024-2034)
1.2.2 Therapeutics
1.2.3 Vaccines
1.3 RNA-based Biopharmaceuticals Segment by Application
1.3.1 Global RNA-based Biopharmaceuticals Market Value by Application: (2024-2034)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Tuberculosis
1.3.5 Cardiovascular Diseases
1.3.6 Others
1.4 Global RNA-based Biopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global RNA-based Biopharmaceuticals Revenue 2018-2034
1.4.2 Global RNA-based Biopharmaceuticals Sales 2018-2034
1.4.3 Global RNA-based Biopharmaceuticals Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 RNA-based Biopharmaceuticals Market Competition by Manufacturers
2.1 Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
2.2 Global RNA-based Biopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)
2.3 Global RNA-based Biopharmaceuticals Average Price by Manufacturers (2018-2023)
2.4 Global RNA-based Biopharmaceuticals Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of RNA-based Biopharmaceuticals, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of RNA-based Biopharmaceuticals, Product Type & Application
2.7 RNA-based Biopharmaceuticals Market Competitive Situation and Trends
2.7.1 RNA-based Biopharmaceuticals Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest RNA-based Biopharmaceuticals Players Market Share by Revenue
2.7.3 Global RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA-based Biopharmaceuticals Retrospective Market Scenario by Region
3.1 Global RNA-based Biopharmaceuticals Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global RNA-based Biopharmaceuticals Global RNA-based Biopharmaceuticals Sales by Region: 2018-2034
3.2.1 Global RNA-based Biopharmaceuticals Sales by Region: 2018-2023
3.2.2 Global RNA-based Biopharmaceuticals Sales by Region: 2024-2034
3.3 Global RNA-based Biopharmaceuticals Global RNA-based Biopharmaceuticals Revenue by Region: 2018-2034
3.3.1 Global RNA-based Biopharmaceuticals Revenue by Region: 2018-2023
3.3.2 Global RNA-based Biopharmaceuticals Revenue by Region: 2024-2034
3.4 North America RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.4.1 North America RNA-based Biopharmaceuticals Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America RNA-based Biopharmaceuticals Sales by Country (2018-2034)
3.4.3 North America RNA-based Biopharmaceuticals Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.5.1 Europe RNA-based Biopharmaceuticals Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe RNA-based Biopharmaceuticals Sales by Country (2018-2034)
3.5.3 Europe RNA-based Biopharmaceuticals Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.6.1 Asia Pacific RNA-based Biopharmaceuticals Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific RNA-based Biopharmaceuticals Sales by Country (2018-2034)
3.6.3 Asia Pacific RNA-based Biopharmaceuticals Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.7.1 Latin America RNA-based Biopharmaceuticals Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America RNA-based Biopharmaceuticals Sales by Country (2018-2034)
3.7.3 Latin America RNA-based Biopharmaceuticals Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa RNA-based Biopharmaceuticals Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA-based Biopharmaceuticals Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa RNA-based Biopharmaceuticals Sales by Country (2018-2034)
3.8.3 Middle East and Africa RNA-based Biopharmaceuticals Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global RNA-based Biopharmaceuticals Sales by Type (2018-2034)
4.1.1 Global RNA-based Biopharmaceuticals Sales by Type (2018-2023)
4.1.2 Global RNA-based Biopharmaceuticals Sales by Type (2024-2034)
4.1.3 Global RNA-based Biopharmaceuticals Sales Market Share by Type (2018-2034)
4.2 Global RNA-based Biopharmaceuticals Revenue by Type (2018-2034)
4.2.1 Global RNA-based Biopharmaceuticals Revenue by Type (2018-2023)
4.2.2 Global RNA-based Biopharmaceuticals Revenue by Type (2024-2034)
4.2.3 Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2018-2034)
4.3 Global RNA-based Biopharmaceuticals Price by Type (2018-2034)
5 Segment by Application
5.1 Global RNA-based Biopharmaceuticals Sales by Application (2018-2034)
5.1.1 Global RNA-based Biopharmaceuticals Sales by Application (2018-2023)
5.1.2 Global RNA-based Biopharmaceuticals Sales by Application (2024-2034)
5.1.3 Global RNA-based Biopharmaceuticals Sales Market Share by Application (2018-2034)
5.2 Global RNA-based Biopharmaceuticals Revenue by Application (2018-2034)
5.2.1 Global RNA-based Biopharmaceuticals Revenue by Application (2018-2023)
5.2.2 Global RNA-based Biopharmaceuticals Revenue by Application (2024-2034)
5.2.3 Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2018-2034)
5.3 Global RNA-based Biopharmaceuticals Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer RNA-based Biopharmaceuticals Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Roche
6.2.1 Roche Corporation Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Roche RNA-based Biopharmaceuticals Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Sanofi-Aventis
6.3.1 Sanofi-Aventis Corporation Information
6.3.2 Sanofi-Aventis Description and Business Overview
6.3.3 Sanofi-Aventis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi-Aventis RNA-based Biopharmaceuticals Product Portfolio
6.3.5 Sanofi-Aventis Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Abbott Laboratories RNA-based Biopharmaceuticals Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Arrowhead Pharmaceuticals
6.5.1 Arrowhead Pharmaceuticals Corporation Information
6.5.2 Arrowhead Pharmaceuticals Description and Business Overview
6.5.3 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product Portfolio
6.5.5 Arrowhead Pharmaceuticals Recent Developments/Updates
6.6 Benitec Biopharma
6.6.1 Benitec Biopharma Corporation Information
6.6.2 Benitec Biopharma Description and Business Overview
6.6.3 Benitec Biopharma RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Benitec Biopharma RNA-based Biopharmaceuticals Product Portfolio
6.6.5 Benitec Biopharma Recent Developments/Updates
6.7 Calimmune Inc
6.6.1 Calimmune Inc Corporation Information
6.6.2 Calimmune Inc Description and Business Overview
6.6.3 Calimmune Inc RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Calimmune Inc RNA-based Biopharmaceuticals Product Portfolio
6.7.5 Calimmune Inc Recent Developments/Updates
6.8 Dicerna
6.8.1 Dicerna Corporation Information
6.8.2 Dicerna Description and Business Overview
6.8.3 Dicerna RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dicerna RNA-based Biopharmaceuticals Product Portfolio
6.8.5 Dicerna Recent Developments/Updates
6.9 Gradalis
6.9.1 Gradalis Corporation Information
6.9.2 Gradalis Description and Business Overview
6.9.3 Gradalis RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Gradalis RNA-based Biopharmaceuticals Product Portfolio
6.9.5 Gradalis Recent Developments/Updates
6.10 Quark
6.10.1 Quark Corporation Information
6.10.2 Quark Description and Business Overview
6.10.3 Quark RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Quark RNA-based Biopharmaceuticals Product Portfolio
6.10.5 Quark Recent Developments/Updates
6.11 RXi
6.11.1 RXi Corporation Information
6.11.2 RXi RNA-based Biopharmaceuticals Description and Business Overview
6.11.3 RXi RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RXi RNA-based Biopharmaceuticals Product Portfolio
6.11.5 RXi Recent Developments/Updates
6.12 Senesco
6.12.1 Senesco Corporation Information
6.12.2 Senesco RNA-based Biopharmaceuticals Description and Business Overview
6.12.3 Senesco RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Senesco RNA-based Biopharmaceuticals Product Portfolio
6.12.5 Senesco Recent Developments/Updates
6.13 Silence Therapeutics
6.13.1 Silence Therapeutics Corporation Information
6.13.2 Silence Therapeutics RNA-based Biopharmaceuticals Description and Business Overview
6.13.3 Silence Therapeutics RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Silence Therapeutics RNA-based Biopharmaceuticals Product Portfolio
6.13.5 Silence Therapeutics Recent Developments/Updates
6.14 Silenseed
6.14.1 Silenseed Corporation Information
6.14.2 Silenseed RNA-based Biopharmaceuticals Description and Business Overview
6.14.3 Silenseed RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Silenseed RNA-based Biopharmaceuticals Product Portfolio
6.14.5 Silenseed Recent Developments/Updates
6.15 Tekmira
6.15.1 Tekmira Corporation Information
6.15.2 Tekmira RNA-based Biopharmaceuticals Description and Business Overview
6.15.3 Tekmira RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tekmira RNA-based Biopharmaceuticals Product Portfolio
6.15.5 Tekmira Recent Developments/Updates
6.16 Alnylam Pharmaceuticals
6.16.1 Alnylam Pharmaceuticals Corporation Information
6.16.2 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Description and Business Overview
6.16.3 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product Portfolio
6.16.5 Alnylam Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA-based Biopharmaceuticals Industry Chain Analysis
7.2 RNA-based Biopharmaceuticals Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA-based Biopharmaceuticals Production Mode & Process
7.4 RNA-based Biopharmaceuticals Sales and Marketing
7.4.1 RNA-based Biopharmaceuticals Sales Channels
7.4.2 RNA-based Biopharmaceuticals Distributors
7.5 RNA-based Biopharmaceuticals Customers
8 RNA-based Biopharmaceuticals Market Dynamics
8.1 RNA-based Biopharmaceuticals Industry Trends
8.2 RNA-based Biopharmaceuticals Market Drivers
8.3 RNA-based Biopharmaceuticals Market Challenges
8.4 RNA-based Biopharmaceuticals Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global RNA-based Biopharmaceuticals Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global RNA-based Biopharmaceuticals Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global RNA-based Biopharmaceuticals Market Competitive Situation by Manufacturers in 2024
Table 4. Global RNA-based Biopharmaceuticals Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global RNA-based Biopharmaceuticals Sales Market Share by Manufacturers (2018-2023)
Table 6. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market RNA-based Biopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of RNA-based Biopharmaceuticals, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of RNA-based Biopharmaceuticals, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of RNA-based Biopharmaceuticals, Product Type & Application
Table 12. Global Key Manufacturers of RNA-based Biopharmaceuticals, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RNA-based Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-based Biopharmaceuticals as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RNA-based Biopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global RNA-based Biopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 18. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2018-2023)
Table 19. Global RNA-based Biopharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 20. Global RNA-based Biopharmaceuticals Sales Market Share by Region (2024-2034)
Table 21. Global RNA-based Biopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2018-2023)
Table 23. Global RNA-based Biopharmaceuticals Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global RNA-based Biopharmaceuticals Revenue Market Share by Region (2024-2034)
Table 25. North America RNA-based Biopharmaceuticals Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 27. North America RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 28. North America RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America RNA-based Biopharmaceuticals Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe RNA-based Biopharmaceuticals Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 32. Europe RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 33. Europe RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe RNA-based Biopharmaceuticals Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific RNA-based Biopharmaceuticals Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific RNA-based Biopharmaceuticals Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific RNA-based Biopharmaceuticals Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America RNA-based Biopharmaceuticals Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 42. Latin America RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 43. Latin America RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America RNA-based Biopharmaceuticals Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa RNA-based Biopharmaceuticals Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa RNA-based Biopharmaceuticals Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa RNA-based Biopharmaceuticals Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa RNA-based Biopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa RNA-based Biopharmaceuticals Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global RNA-based Biopharmaceuticals Sales (K Units) by Type (2018-2023)
Table 51. Global RNA-based Biopharmaceuticals Sales (K Units) by Type (2024-2034)
Table 52. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2018-2023)
Table 53. Global RNA-based Biopharmaceuticals Sales Market Share by Type (2024-2034)
Table 54. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Type (2018-2023)
Table 55. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Type (2024-2034)
Table 56. Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2018-2023)
Table 57. Global RNA-based Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Table 58. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2018-2023)
Table 59. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2024-2034)
Table 60. Global RNA-based Biopharmaceuticals Sales (K Units) by Application (2018-2023)
Table 61. Global RNA-based Biopharmaceuticals Sales (K Units) by Application (2024-2034)
Table 62. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2018-2023)
Table 63. Global RNA-based Biopharmaceuticals Sales Market Share by Application (2024-2034)
Table 64. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Application (2018-2023)
Table 65. Global RNA-based Biopharmaceuticals Revenue (US$ Million) by Application (2024-2034)
Table 66. Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2018-2023)
Table 67. Global RNA-based Biopharmaceuticals Revenue Market Share by Application (2024-2034)
Table 68. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2018-2023)
Table 69. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer RNA-based Biopharmaceuticals Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Roche Corporation Information
Table 76. Roche Description and Business Overview
Table 77. Roche RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Roche RNA-based Biopharmaceuticals Product
Table 79. Roche Recent Developments/Updates
Table 80. Sanofi-Aventis Corporation Information
Table 81. Sanofi-Aventis Description and Business Overview
Table 82. Sanofi-Aventis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi-Aventis RNA-based Biopharmaceuticals Product
Table 84. Sanofi-Aventis Recent Developments/Updates
Table 85. Abbott Laboratories Corporation Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Abbott Laboratories RNA-based Biopharmaceuticals Product
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. Arrowhead Pharmaceuticals Corporation Information
Table 91. Arrowhead Pharmaceuticals Description and Business Overview
Table 92. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Arrowhead Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 94. Arrowhead Pharmaceuticals Recent Developments/Updates
Table 95. Benitec Biopharma Corporation Information
Table 96. Benitec Biopharma Description and Business Overview
Table 97. Benitec Biopharma RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Benitec Biopharma RNA-based Biopharmaceuticals Product
Table 99. Benitec Biopharma Recent Developments/Updates
Table 100. Calimmune Inc Corporation Information
Table 101. Calimmune Inc Description and Business Overview
Table 102. Calimmune Inc RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Calimmune Inc RNA-based Biopharmaceuticals Product
Table 104. Calimmune Inc Recent Developments/Updates
Table 105. Dicerna Corporation Information
Table 106. Dicerna Description and Business Overview
Table 107. Dicerna RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Dicerna RNA-based Biopharmaceuticals Product
Table 109. Dicerna Recent Developments/Updates
Table 110. Gradalis Corporation Information
Table 111. Gradalis Description and Business Overview
Table 112. Gradalis RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Gradalis RNA-based Biopharmaceuticals Product
Table 114. Gradalis Recent Developments/Updates
Table 115. Quark Corporation Information
Table 116. Quark Description and Business Overview
Table 117. Quark RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Quark RNA-based Biopharmaceuticals Product
Table 119. Quark Recent Developments/Updates
Table 120. RXi Corporation Information
Table 121. RXi Description and Business Overview
Table 122. RXi RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. RXi RNA-based Biopharmaceuticals Product
Table 124. RXi Recent Developments/Updates
Table 125. Senesco Corporation Information
Table 126. Senesco Description and Business Overview
Table 127. Senesco RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Senesco RNA-based Biopharmaceuticals Product
Table 129. Senesco Recent Developments/Updates
Table 130. Silence Therapeutics Corporation Information
Table 131. Silence Therapeutics Description and Business Overview
Table 132. Silence Therapeutics RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Silence Therapeutics RNA-based Biopharmaceuticals Product
Table 134. Silence Therapeutics Recent Developments/Updates
Table 135. Silenseed Corporation Information
Table 136. Silenseed Description and Business Overview
Table 137. Silenseed RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Silenseed RNA-based Biopharmaceuticals Product
Table 139. Silenseed Recent Developments/Updates
Table 140. Tekmira Corporation Information
Table 141. Tekmira Description and Business Overview
Table 142. Tekmira RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Tekmira RNA-based Biopharmaceuticals Product
Table 144. Tekmira Recent Developments/Updates
Table 145. Alnylam Pharmaceuticals Corporation Information
Table 146. Alnylam Pharmaceuticals Description and Business Overview
Table 147. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Alnylam Pharmaceuticals RNA-based Biopharmaceuticals Product
Table 149. Alnylam Pharmaceuticals Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. RNA-based Biopharmaceuticals Distributors List
Table 153. RNA-based Biopharmaceuticals Customers List
Table 154. RNA-based Biopharmaceuticals Market Trends
Table 155. RNA-based Biopharmaceuticals Market Drivers
Table 156. RNA-based Biopharmaceuticals Market Challenges
Table 157. RNA-based Biopharmaceuticals Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RNA-based Biopharmaceuticals
Figure 2. Global RNA-based Biopharmaceuticals Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global RNA-based Biopharmaceuticals Market Share by Type in 2024 & 2034
Figure 4. Therapeutics Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Global RNA-based Biopharmaceuticals Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global RNA-based Biopharmaceuticals Market Share by Application in 2024 & 2034
Figure 8. Cancer
Figure 9. Diabetes
Figure 10. Tuberculosis
Figure 11. Cardiovascular Diseases
Figure 12. Others
Figure 13. Global RNA-based Biopharmaceuticals Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global RNA-based Biopharmaceuticals Market Size (2018-2034) & (US$ Million)
Figure 15. Global RNA-based Biopharmaceuticals Sales (2018-2034) & (K Units)
Figure 16. Global RNA-based Biopharmaceuticals Average Price (USD/Unit) & (2018-2034)
Figure 17. RNA-based Biopharmaceuticals Report Years Considered
Figure 18. RNA-based Biopharmaceuticals Sales Share by Manufacturers in 2024
Figure 19. Global RNA-based Biopharmaceuticals Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest RNA-based Biopharmaceuticals Players: Market Share by Revenue in 2024
Figure 21. RNA-based Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global RNA-based Biopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2034)
Figure 24. North America RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2034)
Figure 25. U.S. RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2034)
Figure 28. Europe RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2034)
Figure 29. Germany RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific RNA-based Biopharmaceuticals Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific RNA-based Biopharmaceuticals Revenue Market Share by Region (2018-2034)
Figure 36. China RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2034)
Figure 47. Latin America RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2034)
Figure 48. Mexico RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa RNA-based Biopharmaceuticals Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa RNA-based Biopharmaceuticals Revenue Market Share by Country (2018-2034)
Figure 53. Turkey RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E RNA-based Biopharmaceuticals Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of RNA-based Biopharmaceuticals by Type (2018-2034)
Figure 57. Global Revenue Market Share of RNA-based Biopharmaceuticals by Type (2018-2034)
Figure 58. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of RNA-based Biopharmaceuticals by Application (2018-2034)
Figure 60. Global Revenue Market Share of RNA-based Biopharmaceuticals by Application (2018-2034)
Figure 61. Global RNA-based Biopharmaceuticals Price (USD/Unit) by Application (2018-2034)
Figure 62. RNA-based Biopharmaceuticals Value Chain
Figure 63. RNA-based Biopharmaceuticals Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed